The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Related News Articles

Headline
The Cell and Gene Therapy Access Model, which seeks to increase access to treatments for Medicaid enrollees with rare and severe diseases, will initially focus…
Headline
A new report by the National Association of Insurance Commissioners’ Consumer Representatives calls for regulatory oversight to ensure insurers comply…
Headline
Effective July 1, over 52,000 low-income adults in South Dakota will become eligible for Medicaid under the Affordable Care Act, the Centers for Medicare…
Headline
The U.S. Court of Appeals for the 5th Circuit should reverse a district court decision that prevents the Health and Human Services Secretary from implementing…
Headline
The Centers for Disease Control and Prevention is following up on a previous alert of an outbreak of suspected fungal meningitis in Texas, which is now…
Headline
The U.S. Court of Appeals for the 5th Circuit temporarily restored an Affordable Care Act requirement that most health plans cover certain preventive services…